Debates & Insight
Sponsored
Pricing & Market Access Outlook 2015/2016 Edition
Pricing and market access (P&MA) are key issues for the pharma industry as healthcare budgets continue to tighten and the value of innovative drugs, particularly in areas of high unmet need
